We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AdvaMed Slams Risk-Based Class IIIs Plan As Opening Door to Unnecessary PMAs
AdvaMed Slams Risk-Based Class IIIs Plan As Opening Door to Unnecessary PMAs
Devicemakers are asking the FDA to retain the current classification scheme for Class III devices, saying a proposal to establish risk-based categories would require PMAs for many more devices than currently undergo full premarket approval.